Top 4 Foresite Capital Management Iii, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 36.44% | 133.7K | $14K | new | — | 2022-09-30 | |
| VRNA | Verona Pharma PLC. | 29.98% | 1.11M | $11K | new | — | 2022-09-30 | |
| NTRA | Natera, Inc. | 18.41% | 159.2K | $7K | new | — | 2022-09-30 | |
| CBAY | Cymabay Therapeutics, Inc. | 15.17% | 1.64M | $6K | new | — | 2022-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | — | — |
| Top 20 Holdings Unweighted | — | — |
Sign up free to track Foresite Capital Management Iii, Llc, compare funds side by side, and get alerts the moment positions change.